Impaired glycolysis and reduced Foxp3 exon 2 (Foxp3-E2) expression were also observed in iTregs from patients with relapsing-remitting multiple sclerosis (RRMS) and type 1 diabetes (T1D) (45). This evidence concerns the gene FOXP3 and relapsing-remitting multiple sclerosis.